Follow-Up Review of the Drug Enforcement Administration’s Efforts
to Control the Diversion of Controlled Pharmaceuticals

Evaluations and Inspections Report I-2006-004
July 2006
Office of the Inspector General

EXECUTIVE DIGEST BACKGROUND PURPOSE, SCOPE, AND METHODOLOGY RESULTS OF THE REVIEW Improvements in the DEA’s Pharmaceutical Diversion Control Program Diversion of Controlled Pharmaceuticals Using the Internet Continuing Concerns in the DEA’s Diversion Control Program CONCLUSION AND RECOMMENDATIONS APPENDICES: GROUP SUPERVISOR QUESTIONNAIRE SCOPE OF THE OIG REVIEW REGARDING CONTROLLED SUBSTANCES AND COMMODITIES DEA’S RESPONSE TO DRAFT REPORT OIG’S ANALYSIS OF DEA’S RESPONSE